ClinicalTrials.Veeva

Menu

Validation of a Seizure Monitoring System

S

St Vincent's Hospital Melbourne

Status

Completed

Conditions

Epilepsy

Treatments

Device: Medtronic LINQ Device

Study type

Observational

Funder types

Other

Identifiers

NCT03465189
HREC/18/SVHM/50

Details and patient eligibility

About

The investigators aim to determine the feasibility of using the Medtronic LINQ device for epilepsy diagnosis, monitoring and management. The feasibility will be determined by comparing EEG signals from the LINQ system to the gold standard clinical recordings. If seizures can be identified using the LINQ device with the same level of accuracy as adjacent scalp EEG recording electrodes, then the LINQ will be deemed feasible.

Enrollment

10 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with epilepsy

Exclusion criteria

  • Women that are pregnant
  • Patients that are highly dependant on medical care
  • Patients that cannot give informed consent for themselves

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems